Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VedaLab is Europe’s largest real manufacturer of in vitro immunodiagnostic rapid tests. Their products cover both human and veterinary applications for professional and home use. They offer a wide range of CE-marked rapid diagnostic kits—both qualitative and quantitative—including hormone assays, infectious disease detection, drug screening panels, cardiac markers, gastrointestinal inflammation markers (e.g., calprotectin), among others. The company has developed proprietary readers like Easy Reader+ to enable quantitative analysis at point-of-care settings.
Their clinical results are consistent with regulatory requirements for IVDs in Europe; some products have FDA 510(k) clearance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VedaLab.